Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Distributions in Excess of Cumulative Earnings	Distributions in Excess of Cumulative Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Total Stockholders' Equity	Total Stockholders' Equity Cumulative Effect, Period of Adoption, Adjustment	Non- Controlling Interests	Non- Controlling Interests Cumulative Effect, Period of Adoption, Adjustment
Balance at beginning of period (in shares) at Dec. 31, 2019			83,761,151
Balance at beginning of period at Dec. 31, 2019	$ 1,202,113	$ (188)	$ 838	$ 1,223,043	$ (27,482)	$ (187)	$ (1,949)	$ 1,194,450	$ (187)	$ 7,663	$ (1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance (in shares)			22,554,057
Common stock issuance	477,799		$ 225	477,574				477,799
Costs related to issuance of common stock	(18,154)			(18,154)				(18,154)
Other comprehensive income (loss)	(35,445)						(35,232)	(35,232)		(213)
Equity based compensation expense (in shares)			46,316
Equity based compensation expense	6,078		$ 1	6,077				6,078
Dividends declared on common stock and OP Units	(92,783)				(92,269)			(92,269)		(514)
Net income	42,528				42,273			42,273		255
Balance at end of period (in shares) at Dec. 31, 2020			106,361,524
Balance at end of period at Dec. 31, 2020	1,581,948		$ 1,064	1,688,540	(77,665)		(37,181)	1,574,758		7,190
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance (in shares)			18,230,721
Common stock issuance	469,200		$ 182	469,018				469,200
Common stock withheld related to net share settlement of equity awards	(353)				(353)			(353)
Costs related to issuance of common stock	(12,153)			(12,153)				(12,153)
Other comprehensive income (loss)	22,508						22,395	22,395		113
Equity based compensation expense (in shares)			56,808
Equity based compensation expense	5,683			5,683				5,683
Dividends declared on common stock and OP Units	(119,241)				(118,689)			(118,689)		(552)
Net income	$ 96,211				95,725			95,725		486
Balance at end of period (in shares) at Dec. 31, 2021	124,649,053		124,649,053
Balance at end of period at Dec. 31, 2021	$ 2,043,803		$ 1,246	2,151,088	(100,982)		(14,786)	2,036,566		7,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance (in shares)			17,576,684
Common stock issuance	413,845		$ 178	413,667				413,845
Common stock withheld related to net share settlement of equity awards	(2,452)				(2,452)			(2,452)
Costs related to issuance of common stock	(10,939)			(10,939)				(10,939)
Other comprehensive income (loss)	56,762						55,505	55,505		1,257
Equity based compensation expense (in shares)			153,918
Equity based compensation expense	9,489			9,489				9,489
Dividends declared on common stock and OP Units	(148,479)				(147,883)			(147,883)		(596)
Net income	$ 134,742				134,130			134,130		612
Balance at end of period (in shares) at Dec. 31, 2022	142,379,655		142,379,655
Balance at end of period at Dec. 31, 2022	$ 2,496,771		$ 1,424	$ 2,563,305	$ (117,187)		$ 40,719	$ 2,488,261		$ 8,510